Story perspectives

FDA Recalls 140,000 Atorvastatin Bottles Over Effectiveness Issues

10/29/2025

50 4

Summary

Story summary

The U.S. Food and Drug Administration announced a Class II recall of more than 140,000 bottles of atorvastatin calcium, the generic Lipitor, due to failed dissolution specifications that may reduce effectiveness.
Ascend Laboratories initiated the recall, and it covers 10 mg, 20 mg, 40 mg, and 80 mg dosages.
Patients should check their prescriptions and consult their doctors for guidance on next steps, as no specific public instructions were issued.

1 of 1

Story summary

The U.S. Food and Drug Administration announced a Class II recall of more than 140,000 bottles of atorvastatin calcium, the generic Lipitor, due to failed dissolution specifications that may reduce effectiveness.
Ascend Laboratories initiated the recall, and it covers 10 mg, 20 mg, 40 mg, and 80 mg dosages.
Patients should check their prescriptions and consult their doctors for guidance on next steps, as no specific public instructions were issued.